TNDM Key Statistics, Chart & Performance
The current stock price of TNDM is 21.7 USD. In the past month the price increased by 1.17%. In the past year, price decreased by -39.72%.
TNDM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.23 | 218.96B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.09 | 207.82B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.1 | 144.75B | ||
| SYK | STRYKER CORP | 27.91 | 140.55B | ||
| BDX | BECTON DICKINSON AND CO | 14.06 | 57.87B | ||
| IDXX | IDEXX LABORATORIES INC | 56.57 | 56.96B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.40B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.02 | 39.76B | ||
| RMD | RESMED INC | 25.5 | 36.85B | ||
| DXCM | DEXCOM INC | 36.24 | 26.29B | ||
| PODD | INSULET CORP | 63.25 | 20.33B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.48 | 18.40B |
Related stock screener links
About TNDM
Company Profile
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. The company is headquartered in San Diego, California and currently employs 2,650 full-time employees. The company went IPO on 2013-11-13. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
Company Info
TANDEM DIABETES CARE INC
12400 High Bluff Drive
San Diego CALIFORNIA 92121 US
CEO: John F. Sheridan
Employees: 2650
Phone: 18583666900
TANDEM DIABETES CARE INC / TNDM FAQ
What does TANDEM DIABETES CARE INC do?
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. The company is headquartered in San Diego, California and currently employs 2,650 full-time employees. The company went IPO on 2013-11-13. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
What is the stock price of TANDEM DIABETES CARE INC today?
The current stock price of TNDM is 21.7 USD. The price decreased by -3.56% in the last trading session.
Does TANDEM DIABETES CARE INC pay dividends?
TNDM does not pay a dividend.
How is the ChartMill rating for TANDEM DIABETES CARE INC?
TNDM has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is TANDEM DIABETES CARE INC (TNDM) stock traded?
TNDM stock is listed on the Nasdaq exchange.
How is the market expecting TNDM stock to perform?
30 analysts have analysed TNDM and the average price target is 23.55 USD. This implies a price increase of 8.54% is expected in the next year compared to the current price of 21.7.
What is the GICS sector and industry of TNDM stock?
TANDEM DIABETES CARE INC (TNDM) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
TNDM Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to TNDM. When comparing the yearly performance of all stocks, TNDM turns out to be only a medium performer in the overall market: it outperformed 55.67% of all stocks.
TNDM Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TNDM. Both the profitability and financial health of TNDM have multiple concerns.
TNDM Financial Highlights
Over the last trailing twelve months TNDM reported a non-GAAP Earnings per Share(EPS) of -1.44. The EPS increased by 16.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -23.25% | ||
| ROE | -152.95% | ||
| Debt/Equity | 2.37 |
TNDM Forecast & Estimates
30 analysts have analysed TNDM and the average price target is 23.55 USD. This implies a price increase of 8.54% is expected in the next year compared to the current price of 21.7.
For the next year, analysts expect an EPS growth of -29.58% and a revenue growth 10.11% for TNDM